Based on bioinformatics study, some differentially expressed genes (DEGs) such as Transforming Growth Factor Beta Induced (TGFBI) and SRY-Box 4 (SOX4) were explored as the potential therapy targets for GBM [7]. Here, SOX4 is linked to glioblastoma.